Epistaxis management on COVID‐19–positive patients: Our early case experience and treatment

Samba Siva R. Bathula; Tyler Patrick; Luxman Srikantha

doi:10.1002/ccr3.3137

Clinical Case Reports (Nov 2020)

Epistaxis management on COVID‐19–positive patients: Our early case experience and treatment

Samba Siva R. Bathula,
Tyler Patrick,
Luxman Srikantha

Affiliations

Samba Siva R. Bathula: Department of Otolaryngology ‐ Head and Neck Surgery Detroit Medical Center Detroit MI USA
Tyler Patrick: Department of Otolaryngology ‐ Head and Neck Surgery Detroit Medical Center Detroit MI USA
Luxman Srikantha: Department of Otolaryngology ‐ Head and Neck Surgery Detroit Medical Center Detroit MI USA

DOI: https://doi.org/10.1002/ccr3.3137
Journal volume & issue: Vol. 8, no. 11
pp. 2195 – 2198

Abstract

Read online

Abstract Epistaxis management on COVID‐19 patients is concerning for otolaryngologists due to the highly virulence and increased concentration within respiratory droplets and nasal secretions. Authors suggest initial management with oxymetazoline nasal drops and local pressure before considering nasal packing with absorbable material to prevent COVID‐19 transmission to surrounding healthcare workers.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords